BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 15686658)

  • 1. Impact of ischemia/reperfusion on transplanted livers procured from elderly cadaveric donors.
    Santori G; Andorno E; Morelli N; Gianelli Castiglione A; Casaccia M; Saltalamacchia L; Panaro F; Cottalasso D; Valente U
    Transplant Proc; 2004 Dec; 36(10):2909-13. PubMed ID: 15686658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation.
    Jassem W; Koo DD; Cerundolo L; Rela M; Heaton ND; Fuggle SV
    Transplantation; 2003 Dec; 76(11):1599-603. PubMed ID: 14702531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of microperfusion disturbances in the transplanted liver after Kupffer cell destruction using GdCl3: an experimental porcine study.
    Jahnke C; Mehrabi A; Golling M; Frankenberg MV; Kashfi A; Nentwich H; Fonouni H; Nickkholgh A; Schemmer P; Gutt CN; Weitz J; Schmidt J; Gebhard MM; Büchler MW; Kraus T
    Transplant Proc; 2006 Jun; 38(5):1588-95. PubMed ID: 16797363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Revitalizing donor livers after cardiovascular arrest with venous oxygen persufflation].
    Saad S; Minor T; Nagelschmidt M; Fu ZX; Kötting I; Paul A; Troidl H; Isselhard W
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115(Suppl I):705-8. PubMed ID: 14518345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymoglobulin induction protects liver allografts from ischemia/reperfusion injury.
    Bogetti D; Sankary HN; Jarzembowski TM; Manzelli A; Knight PS; Thielke J; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Clin Transplant; 2005 Aug; 19(4):507-11. PubMed ID: 16008596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of different cadaveric donor age cut-offs on adult recipient survival after liver transplantation: a single-center analysis.
    Santori G; Andorno E; Morelli N; Bottino G; Mondello R; Gianelli Castiglione A; Valente U
    Transplant Proc; 2005; 37(6):2576-81. PubMed ID: 16182749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ischemic preconditioning of cadaver donor livers protects allografts following transplantation.
    Jassem W; Fuggle SV; Cerundolo L; Heaton ND; Rela M
    Transplantation; 2006 Jan; 81(2):169-74. PubMed ID: 16436958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver damage during ischemia/reperfusion and glutathione: implications for potential organ donors.
    Vairetti M; Ferrigno A; Rizzo V; Richelmi P; Cillo U; Imberti R
    Transplant Proc; 2007; 39(6):1768-70. PubMed ID: 17692607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatic ischemia/reperfusion injury can be modulated with thymoglobulin induction therapy.
    Bogetti D; Jarzembowski TM; Sankary HN; Manzelli A; Knight PS; Chejfec G; Cotler S; Oberholzer J; Testa G; Benedetti E
    Transplant Proc; 2005; 37(1):404-6. PubMed ID: 15808659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usage and outcomes of deceased donor liver allografts with preprocurement injury from blunt trauma.
    Geenen IL; Sosef MN; Shun A; Crawford M; Gallagher J; Strasser S; Stormon M; McCaughan G; Verran DJ
    Liver Transpl; 2009 Mar; 15(3):321-5. PubMed ID: 19242992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orthotopic liver transplantation in a young adult (33 years old) using an 84-year-old donor.
    Santori G; Cottalasso D; Antonucci A; Genzone A; Mondello R; Valente R; Morelli N; Fontana I; Andorno E; Valente U
    Hepatogastroenterology; 2001; 48(40):1138-41. PubMed ID: 11490818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-heart-beating versus cadaveric and living-donor livers: differences in inflammatory markers before transplantation.
    Jassem W; Koo DD; Muiesan P; Cerundolo L; Rela M; Fuggle SV; Heaton ND
    Transplantation; 2003 Apr; 75(8):1386-90. PubMed ID: 12717235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience.
    Kaczmarek B; Manas MD; Jaques BC; Talbot D
    Transplant Proc; 2007 Nov; 39(9):2793-5. PubMed ID: 18021989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver fatty acid-binding protein: an early and sensitive plasma marker of hepatocellular damage and a reliable predictor of graft viability after liver transplantation from non-heart-beating donors.
    Monbaliu D; de Vries B; Crabbé T; van Heurn E; Verwaest C; Roskams T; Fevery J; Pirenne J; Buurman WA
    Transplant Proc; 2005; 37(1):413-6. PubMed ID: 15808662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocyte infiltration and inflammatory antigen expression in cadaveric and living-donor livers before transplant.
    Jassem W; Koo DD; Cerundolo L; Rela M; Heaton ND; Fuggle SV
    Transplantation; 2003 Jun; 75(12):2001-7. PubMed ID: 12829901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower expression of Nrf2 mRNA in older donor livers: a possible contributor to increased ischemia-reperfusion injury?
    Zaman MB; Leonard MO; Ryan EJ; Nolan NP; Hoti E; Maguire D; Mulcahy H; Traynor O; Taylor CT; Hegarty JE; Geoghegan JG; O'Farrelly C
    Transplantation; 2007 Nov; 84(10):1272-8. PubMed ID: 18049112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic neutrophil activation during reperfusion may not contribute to initial graft function after short cold ischemia in human liver transplantation.
    Ilmakunnas M; Höckerstedt K; Mäkisalo H; Siitonen S; Repo H; Pesonen EJ
    Transplant Proc; 2009 Mar; 41(2):739-42. PubMed ID: 19328969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney transplantation from elderly donors: a prospective randomized study comparing celsior and UW solutions.
    Montalti R; Nardo B; Capocasale E; Mazzoni MP; Dalla Valle R; Busi N; Beltempo P; Bertelli R; Puviani L; Pacilè V; Fuga G; Faenza A
    Transplant Proc; 2005; 37(6):2454-5. PubMed ID: 16182706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.
    Yagci G; Fernandez LA; Knechtle SJ; D'Alessandro AM; Chin LT; Musat AI; Lucey MR; Said A; Pirsch JD; Leverson G; Kalayoglu M
    Transplant Proc; 2008; 40(1):219-23. PubMed ID: 18261591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantations with donors aged 60 years and above: the low liver damage strategy.
    Ravaioli M; Grazi GL; Cescon M; Cucchetti A; Ercolani G; Fiorentino M; Panzini I; Vivarelli M; Ramacciato G; Del Gaudio M; Vetrone G; Zanello M; Dazzi A; Zanfi C; Di Gioia P; Bertuzzo V; Lauro A; Morelli C; Pinna AD
    Transpl Int; 2009 Apr; 22(4):423-33. PubMed ID: 19040483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.